Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
European Buy-rated Stocks That Trade Cheaply Vs. Their U.S. Peers - UBS
Bristol Myers' Opdivo Fails in Phase 3 Lung Cancer Study
Bristol Myers (NYSE:BMY) said that a Phase 3 study of Opdivo with Yervoy with in the treatment of advanced lung cancer failed to meet its primary endpoint of progression-free survival.
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
It's been a quiet week in the markets, marked by a dearth of major economic news and a consistent flow of positive indicators from the first-quarter earnings season.As of May 7, 424 companies in the S
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo).TAMARACK is being conducted in previously treated patients with metastatic
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 9 unusual trades.Delving into the details, we found
Novavax Hits a 52-week High as Sanofi Deal Prompts J.P. Morgan Upgrade
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday?
Friday, Aethlon Medical Inc (NASDAQ:AEMD) released results from an in vitro binding study of its Hemopurifier in removing extracellular vesicles (EVs) from plasma. Extracellular vesicles contribute to
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
The Food and Drug Administration (FDA) notified Moderna Inc (NASDAQ:MRNA) on Friday that its review of a new vaccine has been delayed.The agency, citing administrative constraints, does not expect to
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Gilead's Kite, Arcellx Share Phase 3 Trial Design for CAR-T Multiple Myeloma Asset
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.Looking at options history for Pfizer (NYSE:PFE) we detected 27 trades.If we consider the specifics of each trade,
Exact Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 46.33% Citigroup $100 → $80 Maintains Buy 04/03/2024 82.92% Citigroup → $100 Maintains Buy 02/2
10 Health Care Stocks With Whale Alerts In Today's Session
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising uptick in unemployment claims prompting speculation over Federal Reserve i
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.The company posted revenue of $1.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersZai Lab (NASDAQ:ZLAB) stock increased by 21.5% to $20.14 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q1 earnings
Merck Says Keytruda Failed as First-line Therapy for Uterine Cancer
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Other Big Stocks Moving Lower
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation (NASDAQ:EXAS) fell sharply in today's pre-market trading aft
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech pioneer, unequivocally backed the mRNA technology, w